1Fahy JV,Corry DB,Boushey HA.Airway inflamation and remodeling in asthma.Curr Opin Pulm Med,2000,6:15 -20
2Elias JA,Zhu Z,Chupp G,Homer RJ.Airway remodeling in asthma.J Clin Invest,1999,104:1001-1006
3Laitinen LA,Laitinen A,Haahtela T.A comparative study of the effects of aninhaled corticosteroid,budesonide,and a beta 2-agonist,terbutaline,on airway inflammmation in newly diagnosed asthma:a randomized,double-blind,parallel-group controlled trial.J Allergy Clin Immunol,1992,90:32 ～ 42
4Zwick E,Hackel PO,Prenzel N,et al.The EGF receptor as central transducer of heterologous signaling systerms.Tips,1999,20(2):408
5Eitzman DT,McCoy RD,Zheng X,et al.Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene.J Clin Invest,1996,97:232-237
6Cho SH,Cho JJ,Kim IS,et al.Identification and characterization of the inducible murine mast cell gene,imc-415.Biochem Biophys Res Commun,1998,252:123-127
7Kelly MM,Leigh R,Bonniaud P,et al.Epithelial expression of profibrotic mediators in a model of allergen-induced airway remodeling.Am J Respir Cell Mol Biol,2005,32(2):99-107
8Buckova D,Izakovicova Holla L,Vacha J.Polymorphism 4G/5G in the plasminogen activator inhibitor-1 (PAI-1) gene is associated with IgE-mediated allergic diseases and asthma in the Czech population.Allergy,2002,57:446-448
9Banach-Wawrzenczyk E,Dziedziczko A,Rosc D.Fibrinolytic system in bronchial asthma after prednisone treatment.Pol Merkuriusz Lek,2000,7(43):9 ～ 11
10Tutluoglu B,Gurel CB,Ozdas SB,et al.Platelet function and fibrinolytic activity in patients with bronchial asthma.Clin Appl Thromb Hemost,2005,11 (1):77 ～ 81
2Eddy AA. Serine proteases, inhibitors and receptors in renal fibrosis. Thromb Haemost, 2009,101 : 656-664.
3Ha H, Oh EY, Lee HB. The role of plasminogen activator inhibitor 1 in renal and cardiovascular diseases. Nat Rev Nephrol,2009,5:203- 211.
4Henry M, Tregouet DA, Alessi MC, et al. Metabolic determinants are much more important than genetic polymorphisms in determining the PAI-1 activity and antigen plasma concentrations: a family study with part of the Stanislas Cohort. Arterioscler Thromb Vasc Biol, 1998, 18: 84-91.
5Adamski MG, Turaj W, Slowik A, et al. A C-4G haplotype of PAI-1 gene polymorphisms 844 G/A, HindIII G/C, and- 675 4G/SG is associated with increased risk of ischemic stroke caused by small vessel disease. Aeta Neurol Scand, 2009,120:94-100.
6Muetze S, Eggermann T, Leeners B, et al. The 4G/5G polymorphism in the plasminogen activator inhibitor 1 gene is not associated with HELLP syndrome. J Thromb Thrombolysis, 2009,27 : 141-145.
7Coulam CB, Wallis D, Weinstein J, et al. Comparison of thrombophilic gene mutations among patients experiencing recurrent miscarriage and deep vein thrombosis. Am J Reprod Immunol,2008,60:426 -431.
8Ozbek OY, Atac FB, Ogus E, et al. Plasminogen activator inhibitor-1 gene 4G/SG polymorphism in Turkish children with asthma and allergic rhinitis. Allergy Asthma Proc, 2009, 30,41- 46.
10Yamada N, Arinami T, Yamakawa Kobayashi K,et al. The 4G/5G polymorphism of the plasminogen activator inhibitoal gene is associated with severe preeclampsia. J Hum Genet, 2000,45 : 138-141.
